The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 23, 2018
Filed:
Mar. 14, 2014
Applicant:
Dana-farber Cancer Institutes, Inc., Boston, MA (US);
Inventors:
Loren D. Walensky, Newton Centre, MA (US);
Michelle L. Stewart, Brookline, MA (US);
Lauren Barclay, Brookline, MA (US);
Assignee:
Dana-Farber Cancer Institute, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); A61K 38/17 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 45/06 (2006.01); G01N 33/68 (2006.01); A61K 49/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4747 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 38/1761 (2013.01); A61K 45/06 (2013.01); A61K 49/0008 (2013.01); G01N 33/68 (2013.01); A61K 38/00 (2013.01); G01N 2333/47 (2013.01); G01N 2500/04 (2013.01); G01N 2500/20 (2013.01);
Abstract
Provided herein are polypeptides containing stabilized BH4 domains of BCL-2 family proteins that are capable of binding and/or inactivating and/or modulating BAX protein, and/or its close homologs BAK and BOK, and/or other physiological BH4 targets. Also provided are compositions containing these polypeptides and methods of treating cytotoxic diseases that include administering to a subject one of the polypeptides.